| 000 | 01594 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515234242.0 | ||
| 264 | 0 | _c20101130 | |
| 008 | 201011s 0 0 eng d | ||
| 022 | _a0971-5916 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnantharaman, R | |
| 245 | 0 | 0 |
_aAnti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy. _h[electronic resource] |
| 260 |
_bThe Indian journal of medical research _cJul 2010 |
||
| 300 |
_a42-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlbumins _xmetabolism |
| 650 | 0 | 4 |
_aAlbuminuria _xdrug therapy |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzoates _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xcomplications |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPotassium _xblood |
| 650 | 0 | 4 |
_aRamipril _xtherapeutic use |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aTelmisartan |
| 700 | 1 | _aBhansali, Anil | |
| 700 | 1 | _aBhadada, Sanjay K | |
| 700 | 1 | _aKohli, Harbir S | |
| 700 | 1 | _aDutta, Pinaki | |
| 700 | 1 | _aWalia, Rama | |
| 700 | 1 | _aJayaprakash, P | |
| 700 | 1 | _aUpreti, Vimal | |
| 773 | 0 |
_tThe Indian journal of medical research _gvol. 132 _gp. 42-7 |
|
| 999 |
_c20032018 _d20032018 |
||